Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Count of severe COVID-19 no higher in children during second wave compared to first wave

Researchers in the UK have conducted a study suggesting that severe disease in children and young people admitted to hospital following infection with severe acute respiratory syndrome coronavirus (SARS-CoV-2) is still rare and was no more common during the second wave of infections than the first.

21 Sep 2021

Researchers investigate students' belonging insecurity in a STEM course

As a first-year college student in an introductory chemistry class sits down for their midterm, which might be their first stepping stone toward a career in academia, research or medicine, a thought may swirl through their head alongside valence numbers, molar masses and oxidation states-;an anxiety that forms itself into a supposition: "Maybe people like me don't belong in this class."

21 Sep 2021

COVID-19 vaccine effectiveness against SARS-CoV-2 variants

A commentary published in the journal Cell summarizes international data on vaccine effectiveness against new severe acute respiratory coronavirus 2 (SARS-CoV-2) variants. Evidence shows that the currently approved vaccines continue to be effective in preventing severe and symptomatic illness — even with the widely circulating Delta variant.

21 Sep 2021

Scientists hypothesize SARS-CoV-2 cryptically circulating among humans before the current outbreak

As nations begin to recover, researchers from the National Taiwan University and Academia Sinica in Taipei have been looking to identify the changes the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) underwent over the course of the pandemic in order to better understand why the disease showed such virulence.

20 Sep 2021

International organizations, vaccine manufacturers discuss strategies to improve access to COVID-19 vaccines

The heads of the International Monetary Fund, World Bank Group, World Health Organization and World Trade Organization met with the CEOs of leading vaccine manufacturing companies to discuss strategies to improve the access to COVID-19 vaccines, especially in low- and lower middle-income countries and in Africa.

20 Sep 2021

New evidence confirms the efficacy of COVID-19 vaccination in cancer patients

The long-awaited confirmation of the efficacy of COVID-19 vaccination in patients with cancer has arrived, on time to be disseminated to a global audience at the annual congress of the European Society for Medical Oncology (ESMO Congress 2021), the leading professional society for medical oncology.

20 Sep 2021

A novel FACS-based approach for SARS-CoV-2 serology

A recent study discusses a simple, sensitive, and quantitative serological test based on FACS assay to evaluate antibodies against SARS-CoV-2.

20 Sep 2021

Role of extracellular vesicles embedded with engineered ACE2 in the neutralization of the SARS-CoV-2 pseudovirus

Researchers discuss the preparation and characterization of EVs-ACE2, along with the production and characterization of SARS-CoV-2 S-pseudovirus.

20 Sep 2021

Scientists simulate SARS-CoV-2 virion envelope using Martini 3

A new study proposes an integrative computational approach to model the structure of the SARS-CoV-2 envelope.

20 Sep 2021

Failures and findings from randomized clinical trials in COVID-19 convalescent plasma

Researchers complete an extensive search on previously published studies to understand the efficacy of convalescent plasma in treating COVID-19.

20 Sep 2021

Study examines relationship between public health behavior and social capital indices during COVID

A recent study examines the relationship among public health behaviors during the COVID-19 pandemic and social capital indices in the United States.

20 Sep 2021

Asymptomatic SARS-CoV-2 infections vary with age and geographical location

In this study, surveillance data were used to investigate how asymptomatic SARS-CoV-2 infections vary by age and geographic location.

20 Sep 2021

What impact has SARS-CoV-2 variant B.1.1.519 had on Mexico City?

The current study reports the effective reproduction number of B.1.1.519 and presents its geographical origin based on phylogenetic analysis.

20 Sep 2021

I got a ‘mild’ breakthrough case. Here’s what I wish I’d known.

The test results that hot day in early August shouldn’t have surprised me — all the symptoms were there. A few days earlier, fatigue had enveloped me like a weighted blanket. I chalked it up to my weekend of travel. Next, a headache clamped down on the back of my skull.

20 Sep 2021

Ask KHN-Politifact: Is my cloth mask good enough to face the delta variant?

In recent months, some European airlines have banned the use of cloth face coverings to control the spread of the coronavirus during air travel, instead favoring surgical masks — sometimes referred to as medical or disposable — and N95 respirators.

20 Sep 2021

EIT Health highlights the urgent need for harnessing data and AI to fight against Alzheimer’s disease

To coincide with World Alzheimer’s Month, EIT Health, an EU-backed network of best-in-class health innovators, has highlighted the urgent need to focus on implementing bolder approaches to the treatment of Alzheimer’s Disease post-pandemic.

20 Sep 2021

Medical staff with a history of allergy suffered adverse reactions to BNT162b2 COVID-19 vaccine

Scientists have addressed the gap in the research regarding the adverse reactions to the COVID-19 vaccine among individuals with allergies.

20 Sep 2021

First dose of COVID-19 mRNA vaccine (BNT162b2) reduced platelet polyP levels in young females

In a recent study, scientists have tested the hypothesis that indicates the role of polyP in the COVID-19 mRNA vaccine-induced immune responses.

20 Sep 2021

New surgical mask with an intelligent fabric can instantaneously deactivate SARS-COV-2 virus

The intelligent fabric of these masks has been created by a team of researchers from the San Alberto Magno Traslational Centre (CITSAM-UCV), led by professor Ángel Serrano.

20 Sep 2021

Myocarditis risk from mRNA COVID vaccines re-evaluated in Canadian study (Research Now Withdrawn)

Scientists from the University of Ottawa, Canada, have recently estimated the prevalence of myocarditis/pericarditis in individuals recently immunized with mRNA-based coronavirus disease 2019 (COVID-19) vaccines. The analysis reveals a prevalence of 10 myopericarditis cases for every 10,000 vaccine doses. The study is currently available on the medRxiv* preprint server.

20 Sep 2021

Pandemic News and Research

Further Reading

Count of severe COVID-19 no higher in children during second wave compared to first wave

Researchers investigate students' belonging insecurity in a STEM course

COVID-19 vaccine effectiveness against SARS-CoV-2 variants

Scientists hypothesize SARS-CoV-2 cryptically circulating among humans before the current outbreak

International organizations, vaccine manufacturers discuss strategies to improve access to COVID-19 vaccines

New evidence confirms the efficacy of COVID-19 vaccination in cancer patients

A novel FACS-based approach for SARS-CoV-2 serology

Role of extracellular vesicles embedded with engineered ACE2 in the neutralization of the SARS-CoV-2 pseudovirus

Scientists simulate SARS-CoV-2 virion envelope using Martini 3

Failures and findings from randomized clinical trials in COVID-19 convalescent plasma

Study examines relationship between public health behavior and social capital indices during COVID

Asymptomatic SARS-CoV-2 infections vary with age and geographical location

What impact has SARS-CoV-2 variant B.1.1.519 had on Mexico City?

I got a ‘mild’ breakthrough case. Here’s what I wish I’d known.

Ask KHN-Politifact: Is my cloth mask good enough to face the delta variant?

EIT Health highlights the urgent need for harnessing data and AI to fight against Alzheimer’s disease

Medical staff with a history of allergy suffered adverse reactions to BNT162b2 COVID-19 vaccine

First dose of COVID-19 mRNA vaccine (BNT162b2) reduced platelet polyP levels in young females

New surgical mask with an intelligent fabric can instantaneously deactivate SARS-COV-2 virus

Myocarditis risk from mRNA COVID vaccines re-evaluated in Canadian study (Research Now Withdrawn)

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News